An 11‐center Korean study evaluating paired serum and CSF of 474 patients with demyelination identified a CSF‐restricted MOG‐IgG profile in 4/31 (13%) patients with MS, and 9/217 (4%) patients with seronegative demyelination thought to be consistent with MOGAD.5 This evidence concerns the gene MOG and myeloid sarcoma.